DISCLOSURE UNDER REGULATION 29(2) UNDER SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVER) REGULATIONS, 2011
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Sudhir Sethi, a main promoter of Beryl Drugs Ltd, acquired 7,500 equity shares of the company through market transactions on 23-03-2026, representing 0.14% of the total share capital. This takes his individual holding from 4,78,983 shares (9.44%) to 4,86,483 shares (9.58%). The total equity share capital of the company remains unchanged at 50,71,700 shares. The disclosure was filed under SEBI's Takeover Regulations and also lists other promoter-group members including Sanjay Sethi, Sangita Sethi, and Soniya Sethi.
This is a small, routine promoter purchase and is not material in size — at 7,500 shares it is unlikely to move the stock price. However, the promoter is now sitting just below the 10% substantial-shareholder threshold, which is worth watching as further purchases could trigger additional disclosure obligations.